← All diseases

Disease Atlas / Disease detail

Keratosis follicularis spinulosa decalvans

Educational material to help understand the symptoms, diagnosis, management, and research questions of keratosis follicularis spinulosa decalvans.

keratosis follicularis spinulosa decalvans

MONDO:0000136Public QA completeSource-bound · 2

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · d50757ff121a

Disease category
Keratosis follicularis spinulosa decalvans is a rare skin disorder in which abnormal keratinization of hair follicles can occur together with hair loss.
Core mechanism
The inheritance pattern of keratosis follicularis spinulosa decalvans can differ among families, and a family history is identified in some patients.
Main causes and associated factors
Abnormal keratinization of hair follicles and the resulting inflammation are understood to contribute to the skin and hair symptoms of keratosis follicularis spinulosa decalvans.
Typical manifestations
Typical clinical features include follicular keratotic papules on the face and scalp, loss of the eyebrows, eyelashes, or scalp hair, and photosensitivity or eye symptoms in some patients.
Individual variation
The age at onset and the extent and severity of symptoms may differ among families and individuals, and genetic background and environmental factors may contribute to this variation.
Diagnosis
Symptoms often begin in childhood or adolescence, and skin keratinization and hair loss may persist for a long time or progress gradually.
Management
Diagnosis is based on the medical history and examination of the skin and hair, with skin biopsy, ophthalmic evaluation, or genetic testing considered as adjuncts when needed.
Treatment and research status
Similar follicular keratinization disorders or scarring alopecia may be part of the differential diagnosis, so no single test result should establish the diagnosis without interpretation alongside the clinical features.
Reading the evidence
Management may include care of the skin barrier and keratinization symptoms, protection from sunlight and eye symptoms, and regular assessment of hair loss and eye health.
Key caution
Treatment focuses on reducing the burden of skin and eye symptoms and hair loss rather than uniformly eliminating the disorder.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Keratosis follicularis spinulosa decalvans is a rare skin disorder in which abnormal keratinization of hair follicles can occur together with hair loss.

Typical clinical features include follicular keratotic papules on the face and scalp, loss of the eyebrows, eyelashes, or scalp hair, and photosensitivity or eye symptoms in some patients.

How the disorder works

The inheritance pattern of keratosis follicularis spinulosa decalvans can differ among families, and a family history is identified in some patients.

Abnormal keratinization of hair follicles and the resulting inflammation are understood to contribute to the skin and hair symptoms of keratosis follicularis spinulosa decalvans.

How it varies from person to person

The age at onset and the extent and severity of symptoms may differ among families and individuals, and genetic background and environmental factors may contribute to this variation.

Overall approach to diagnosis and management

Symptoms often begin in childhood or adolescence, and skin keratinization and hair loss may persist for a long time or progress gradually.

Diagnosis is based on the medical history and examination of the skin and hair, with skin biopsy, ophthalmic evaluation, or genetic testing considered as adjuncts when needed.

Current state of treatment

Similar follicular keratinization disorders or scarring alopecia may be part of the differential diagnosis, so no single test result should establish the diagnosis without interpretation alongside the clinical features.

Management may include care of the skin barrier and keratinization symptoms, protection from sunlight and eye symptoms, and regular assessment of hair loss and eye health.

Treatment focuses on reducing the burden of skin and eye symptoms and hair loss rather than uniformly eliminating the disorder.

How to read clinical trials

Follow-up should assess changes in the skin and hair, eye symptoms such as visual changes and photosensitivity, and treatment adverse effects; trial registration alone cannot establish treatment efficacy or standard-of-care status.

Points to discuss during a clinical visit

During clinical care, it is important to discuss in detail the onset and changes in symptoms, family history, hair loss and eye symptoms, previous treatments and adverse effects, and difficulties in daily life.

Medical information

This material is for educational purposes and is not a guide for individual diagnosis or treatment.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.